Key Points
-
21–23-nucleotide (nt) double-stranded (ds), short interfering (si)RNAs can silence gene expression by directing the sequence-specific cleavage of target messenger RNA in a process that is referred to as RNA interference (RNAi).
-
Although long dsRNAs have been used successfully for the silencing of gene expression in various organisms including Caenorhabditis elegans, plants, Drosophila and mouse oocytes, their use in mammalian systems has been limited primarily because the introduction of dsRNA longer than 30 nt induces a nonspecific interferon response.
-
The evidence that siRNAs could be introduced into mammalian cells and cause the sequence-specific degradation of mRNA without inducing an interferon response has revolutionized the way in which mammalian somatic-cell genetic studies are approached, laid the ground work for the development of short-RNA-based silencing technologies, and holds promise for the development of potential siRNA-based therapeutic strategies.
-
The use of synthetic siRNAs for gene silencing leads to a transient response. DNA-vector-based delivery systems have been developed, which prolonged the silencing effect indefinitely.
-
Most of these expression systems take advantage of the ability of Dicer to process short hairpin RNAs into siRNAs and thereby silence the target gene. These technologies have made it possible to carry out gene-silencing experiments in various cell types and cell lines, as well as to create transgenic animals that stably silence a target gene.
-
This article discusses the rapid advances in RNAi-based gene-silencing technologies and the impact these advances have on the study of gene function, including the development of transgenic animals, siRNA-mediated gene silencing in somatic tissues and functional-genomic studies.
Abstract
Short interfering RNAs can be used to silence gene expression in a sequence-specific manner in a process that is known as RNA interference. The application of RNA interference in mammals has the potential to allow the systematic analysis of gene expression and holds the possibility of therapeutic gene silencing. Much of the promise of RNA interference will depend on the recent advances in short-RNA-based silencing technologies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Fire, A. et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811 (1998). The first evidence that dsRNA could mediate sequence-specific gene silencing. Silencing was shown to be heritable from parental C. elegans to their progeny.
Jorgensen, R. Altered gene expression in plants due to trans interactions between homologous genes. Trends Biotechnol. 8, 340–344 (1990).
Romano, N. & Macino, G. Quelling: transient inactivation of gene expression in Neurospora crassa by transformation with homologous sequences. Mol. Microbiol. 6, 3343–3353 (1992). Evidence that the ectopic expression of segments of transgenes leads to silencing of the endogenous homologues. This process is known as 'quelling' in Neurospora and is related to PTGS in plants and RNAi in animals.
Bernstein, E., Denli, A. M. & Hannon, G. J. The rest is silence. RNA 7, 1509–1521 (2001).
Grishok, A., Tabara, H. & Mello, C. C. Genetic requirements for inheritance of RNAi in C. elegans. Science 287, 2494–2497 (2000). This study begins to assemble the genes that are involved in RNAi into a pathway and explain the genetic requirements of inheritance of RNAi phenotypes from parents to offspring.
Hamilton, A. J. & Baulcombe, D. C. A species of small antisense RNA in posttranscriptional gene silencing in plants. Science 286, 950–952 (1999).
Zamore, P. D., Tuschl, T., Sharp, P. A. & Bartel, D. P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25–33 (2000). This paper shows the 'processing' of long dsRNA by Dicer into shorter fragments in 21–23-nt intervals in Drosophila extracts and describes the biochemical requirements for the 'dicing' reaction in vitro.
Elbashir, S. M., Lendeckel, W. & Tuschl, T. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15, 188–200 (2001).
Yang, D., Lu, H. & Erickson, J. W. Evidence that processed small dsRNAs may mediate sequence-specific mRNA degradation during RNAi in Drosophila embryos. Curr. Biol. 10, 1191–1200 (2000).
Parrish, S., Fleenor, J., Xu, S., Mello, C. & Fire, A. Functional anatomy of a dsRNA trigger: differential requirement for the two trigger strands in RNA interference. Mol. Cell 6, 1077–1087 (2000).
Hammond, S. M., Bernstein, E., Beach, D. & Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293–296 (2000).
Sullenger, B. A. & Gilboa, E. Emerging clinical applications of RNA. Nature 418, 252–258 (2002).
Kitabwalla, M. & Ruprecht, R. M. RNA interference — a new weapon against HIV and beyond. N. Engl. J. Med. 347, 1364–1367 (2002).
Dornburg, R. & Pomerantz, R. J. HIV-1 gene therapy: promise for the future. Adv. Pharmacol. 49, 229–261 (2000).
Bernstein, E., Caudy, A. A., Hammond, S. M. & Hannon, G. J. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363–366 (2001). The first paper to report the cloning of Dicer. The RNase III enzyme is evolutionarily conserved and contains helicase and PAZ domains, as well as two dsRNA-binding domains.
Ketting, R. F. et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659 (2001).
Billy, E., Brondani, V., Zhang, H., Müller, H. & Filipowicz, W. Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc. Natl Acad. Sci. USA 98, 14428–14433 (2001).
Sharp, P. A. RNA interference — 2001. Genes Dev. 15, 485–490 (2001)
Hannon, G. J. RNA interference. Nature 418, 244–251 (2002).
McManus, M. T. & Sharp, P. A. Gene silencing in mammals by small interfering RNAs. Nature Rev. Genet. 3, 737–747 (2002).
Zamore, P. D. Ancient pathways programmed by small RNAs. Science 296, 1265–1269 (2002).
Hutvagner, G. & Zamore, P. D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 297, 2056–2060 (2002).
Zeng, Y. & Cullen, B. R. RNA interference in human cells is restricted to the cytoplasm. RNA 8, 855–860 (2002).
Kawasaki, H. & Taira, K. Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res. 31, 700–707 (2003).
Nykanen, A., Haley, B. & Zamore, P. D. ATP requirements and small interfering RNA structure in the RNA interference pathway. Cell 107, 309–321 (2001). RNAi requires ATP for long dsRNA cleavage and for siRNA unwinding and maintaining 5′ phosphate on the siRNA. RISC is present in two alternative forms, and the inactive holo-complex can be converted to the active form by incorporation of bona fide siRNA.
Schwarz, D. S., Hutvagner, G., Haley, B. & Zamore, P. D. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell 10, 537–548 (2002).
Pasquinelli, A. E. MicroRNAs: deviants no longer. Trends Genet. 18, 171–173 (2002).
Pasquinelli, A. E. & Ruvkun, G. Control of developmental timing by micrornas and their targets. Annu. Rev. Cell Dev. Biol. 18, 495–513 (2002).
Grishok, A. et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106, 23–34 (2001).
Mourelatos, Z. et al. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720–728 (2002).
Baulcombe, D. C. Gene silencing: RNA makes RNA makes no protein. Curr. Biol. 9, R599–R601 (1999).
Sánchez-Alvarado, A. & Newmark, P. A. Double-stranded RNA specifically disrupts gene expression during planarian regeneration. Proc. Natl Acad. Sci. USA 96, 5049–5054 (1999).
Lohmann, J. U., Endl, I. & Bosch, T. C. G. Silencing of developmental genes in Hydra. Dev. Biol. 214, 211–214 (1999).
Ngô, H., Tschudi, C., Gull, K. & Ullu, E. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc. Natl Acad. Sci. USA 95, 14687–14692 (1998).
Kennerdell, J. R. & Carthew, R. W. Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95, 1017–1026 (1998).
Misquitta, L. & Paterson, B. M. Targeted disruption of gene function in Drosophila by RNA interference (RNA-i): a role for nautilus in embryonic somatic muscle formation. Proc. Natl Acad. Sci. USA 96, 1451–1456 (1999).
Caplen, N. J., Zheng, Z., Falgout, B. & Morgan, R. A. Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference. Mol. Ther. 6, 243–251 (2002).
Svoboda, P., Stein, P., Hayashi, H. & Schultz, R. M. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 127, 4147–4156 (2000).
Wianny, F. & Zernicka-Goetz, M. Specific interference with gene function by double-stranded RNA in early mouse development. Nature Cell Biol. 2, 70–75 (2000).
Elbashir, S. M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001). The first evidence that siRNAs can mediate sequence-specific gene silencing in mammals and that the dicing step can be bypassed by the introduction of siRNA into cells.
Stark, G. et al. How cells respond to interferons. Annu. Rev. Biochem. 67, 227–264 (1998).
Hammond, S. M., Bernstein, E., Beach, D. & Hannon, G. J. An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells. Nature 404, 293–296 (2000).
Caplen, N. J., Fleenor, J., Fire, A. & Morgan, R. A. dsRNA-mediated gene silencing in cultured Drosophila cells: a tissue culture model for the analysis of RNA interference. Gene 252, 95–105 (2000).
Ui-Tei, K., Zenno, S., Miyata, Y. & Saigo, K. Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target. FEBS Lett. 479, 79–82 (2000).
Holen, T., Amarzguioui, M., Wiiger, M. T., Babaie, E. & Prydz, H. Positional effects of short interfering RNAs targeting the human coagulation trigger tissue factor. Nucleic Acids Res. 30, 1757–1766 (2002).
Miyagishi, M. & Taira, K. U6 promoter-driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells. Nature Biotechnol. 20, 497–500 (2002).
Vickers, T. A. et al. Efficient reduction of target RNAs by siRNA and RNase H dependent antisense agents: a comparative analysis. J. Biol. Chem. 278, 7108–7118 (2003).
Hemann, M. T. et al. An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nature Genet. 33, 396–400 (2003).
Yang, D. et al. Short RNA duplexes produced by hydrolysis with Escherichia coli RNase III mediate effective RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA 99, 9942–9947 (2002).
Calegari, F., Haubensak, W., Yang, D., Huttner, W. B. & Buchholz, F. Tissue-specific RNA interference in postimplantation mouse embryos with endoribonuclease-prepared short interfering RNA. Proc. Natl Acad. Sci. USA 99, 14236–14240 (2002).
Kawasaki, H., Suyama, E., Iyo, M. & Taira, K. siRNAs generated by recombinant human Dicer induce specific and significant but target site-independent gene silencing in human cells. Nucleic Acids Res. 31, 981–987 (2003).
Myers, J. W., Jones, J. T., Meyer, T. & Ferrell, J. E. Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing. Nature Biotechnol. 21, 324–328 (2003).
Lee, N. S. et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nature Biotechnol. 20, 500–505 (2002).
Cogoni, C. & Macino, G. Homology-dependent gene silencing in plants and fungi: a number of variations on the same theme. Curr. Opin. Microbiol. 2, 657–662 (1999).
Dalmay, T., Hamilton, A., Rudd, S., Angell, S. & Baulcombe, D. C. An RNA-dependent RNA polymerase gene in Arabidopsis is required for posttranscriptional gene silencing mediated by a transgene but not by a virus. Cell 101, 543–553 (2000).
Sijen, T. et al. On the role of RNA amplification in dsRNA-triggered gene silencing. Cell 107, 465–476 (2001).
Paddison, P. J. & Hannon, G. J. RNA interference: the new somatic cell genetics? Cancer Cell 2, 17–23 (2002).
Chiu, Y. L. & Rana, T. M. RNAi in human cells: basic structural and functional features of small interfering RNA. Mol. Cell 10, 549–561 (2002).
Stein, P., Svoboda, P., Anger, M. & Schultz, R. M. RNAi: mammalian oocytes do it without RNA-dependent RNA polymerase. RNA 9, 187–192 (2003).
Svoboda, P., Stein, P. & Schultz, R. M. RNAi in mouse oocytes and preimplantation embryos: effectiveness of hairpin dsRNA. Biochem. Biophys. Res. Commun. 287, 1099–1104 (2001).
Tavernarakis, N., Wang, S. L., Dorovkov, M., Ryazanov, A. & Driscoll, M. Heritable and inducible genetic interference by double-stranded RNA encoded by transgenes. Nature Genet. 24, 180–183 (2000).
Kennerdell, J. R. & Carthew, R. W. Heritable gene silencing in Drosophila using double-stranded RNA. Nature Biotechnol. 18, 896–898 (2000).
Brummelkamp, T. R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550–53 (2002).
McManus, M. T., Petersen, C. P., Haines, B. B., Chen, J. & Sharp, P. A. Gene silencing using micro-RNA designed hairpins. RNA 8, 842–850 (2002).
Paddison, P. J., Caudy, A. A., Bernstein, E., Hannon, G. J. & Conklin, D. S. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948–958 (2002).
Paddison, P. J., Caudy, A. A. & Hannon, G. J. Stable suppression of gene expression by RNAi in mammalian cells. Proc. Natl Acad. Sci. USA 99, 1443–1448 (2002).
Paul, C. P., Good, P. D., Winer, I. & Engelke, D. R. Effective expression of small interfering RNA in human cells. Nature Biotechnol. 20, 505–508 (2002).
Sui, G. et al. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl Acad. Sci. USA 99, 5515–5520 (2002).
Yu, J. -Y., DeRuiter, S. L. & Turner, D. L. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 99, 6047–6052 (2002).
Paule, M. R. & White, R. J. Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res. 28, 1283–1298 (2000).
Myslinski, E., Ame, J. C., Krol, A. & Carbon, P. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. Nucleic Acids Res. 29, 2502–2509 (2001).
Reinhart, B. J. et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403, 901–906 (2000).
Hutvagner, G. et al. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293, 834–838 (2001). MicroRNAs are genetically related to siRNAs by Dicer processing, and the silencing of Dicer led to accumulation of the prototype microRNA precursor of let-7.
Knight, S. W. & Bass, B. L. A role for the RNase III enzyme DCR-1 in RNA interference and germ line development in Caenorhabditis elegans. Science 293, 2269–2271 (2001).
Brummelkamp, T. R., Bernards, R. & Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243–247 (2002).
Stewart, S. A. et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9, 493–501 (2003).
Rubinson, D. A. et al. A lentivirus-based system to silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401–406 (2003).
Qin, X. F., An, D. S., Chen, I. S. & Baltimore, D. Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl Acad. Sci. USA 100, 183–188 (2003).
Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263–267 (1996).
Svoboda, J., Hejnar, J., Geryk, J., Elleder, D. & Vernerova, Z. Retroviruses in foreign species and the problem of provirus silencing. Gene 261, 181–188 (2000).
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M. & Le Deist, F. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl. J. Med. 348, 255–256 (2003).
Noguchi, P. Risks and benefits of gene therapy. N. Engl. J. Med. 348, 193–194 (2003).
Marshall, E. Gene therapy: second child in French trial is found to have leukemia. Science 299, 320 (2003).
Gordon, J. W. Production of transgenic mice. Methods Enzymol. 225, 747–771 (1993).
Carmell, M. A., Zhang, L., Conklin, D. S., Hannon, G. J. & Rosenquist, T. A. Germline transmission of RNAi in mice. Nature Struct. Biol. 10, 91–92 (2003).
Hasuwa, H., Kaseda, K., Einarsdottir, T. & Okabe, M. Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett. 532, 227–230 (2002).
Lois, C., Hong, E. J., Pease, S., Brown, E. J. & Baltimore, D. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868–872 (2002). Lentiviral vectors are efficient vehicles for gene delivery to embryos and they enable the efficient production of transgenic animals. The lentiviral vector described is the parent vector for many of the lentiviral vectors being used at present to deliver small RNAs.
Tiscornia, G., Singer, O., Ikawa, M. & Verma, I. M. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl Acad. Sci. USA 100, 1844–1848 (2003).
Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 6, 1258–1266 (1999).
Zhang, G., Budker, V. & Wolff, J. A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735–1737 (1999).
Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff, J. A. & Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. 32, 107–108 (2002).
McCaffrey, A. P. et al. RNA interference in adult mice. Nature 418, 38–39 (2002).
Song, E. et al. RNA interference targeting Fas protects mice from fulminant hepatitis. Nature Med. 9, 347–351 (2003). The first report that siRNAs could be used therapeutically in whole animals. Hydrodynamic injection of siRNAs into mice led to silencing of Fas-receptor expression, inhibition of Fas-mediated apoptosis in the liver and the prevention of fulminant hepatitis that would have led to death of the mice.
Gonczy, P. et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408, 331–336 (2000).
Fraser, A. G. et al. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325–330 (2000).
Lee, S. S. et al. A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nature Genet. 33, 40–48 (2003).
Ashrafi, K. et al. Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421, 268–272 (2003).
Kamath, R. S. et al. Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421, 231–237 (2003). RNAi can be used in functional-genomic approaches to uncover the networks of gene that are involved in common processes. This study reports the production and screening of a C. elegans RNAi library representing ∼17,000 genes, which covers 86% of the total number of genes.
Elbashir, S. M., Harborth, J., Weber, K. & Tuschl, T. Analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26, 199–213 (2002).
Martinez, J., Patkaniowska, A., Urlaub, H., Luhrmann, R. & Tuschl, T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 110, 563–574 (2002).
McManus, M. T. et al. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169, 5754–5760 (2002).
Zeng, Y., Wagner, E. J. & Cullen, B. R. Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells. Mol. Cell 9, 1327–1333 (2002).
Xia, H., Mao, Q., Paulson, H. L. & Davidson, B. L. siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol. 20, 1006–1010 (2002).
Novina, C. D. et al. siRNA-directed inhibition of HIV-1 infection. Nature Med. 8, 681–686 (2002).
Capodici, J., Kariko, K. & Weissman, D. Inhibition of HIV-1 infection by small interfering RNA-mediated RNA interference. J. Immunol. 169, 5196–5201 (2002).
Coburn, G. A. & Cullen, B. R. Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76, 9225–9231 (2002).
Jacque, J. M., Triques, K. & Stevenson, M. Modulation of HIV-1 replication by RNA interference. Nature 418, 435–438 (2002).
Gitlin, L., Karelsky, S. & Andino, R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 418, 430–434 (2002).
Jiang, M. & Milner, J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 21, 6041–6048 (2002).
Bitko, V. & Barik, S. Phenotypic silencing of cytoplasmic genes using sequence-specific double-stranded short interfering RNA and its application in the reverse genetics of wild type negative-strand RNA viruses. BMC Microbiol. 1, 34 (2001).
Scherr, M. et al. Specific inhibition of bcr–abl gene expression by small interfering RNA. Blood 101, 1566–1569 (2003).
Wang, B., Matsuoka, S., Carpenter, P. B. & Elledge, S. J. 53BP1, a mediator of the DNA damage checkpoint. Science 298, 1435–1438 (2002).
Kartasheva, N. N., Contente, A., Lenz-Stoppler, C., Roth, J. & Dobbelstein, M. p53 induces the expression of its antagonist p73ΔN, establishing an autoregulatory feedback loop. Oncogene 21, 4715–4727 (2002).
Martinez, M. A. et al. Suppression of chemokine receptor expression by RNA interference allows for inhibition of HIV-1 replication. AIDS 16, 2385–2390 (2002).
Acknowledgements
Owing to the large amount of work that has been done in this field, it was impossible to cover every paper in this review, and we apologize for any oversights. We thank Helen Cargill for preparing the figures and A. Grishok, J. Doench and C. Petersen for their critical reading of the manuscript. Work in our laboratory was supported by a United States Public Health Service MERIT Award from the National Institutes of Health (NIH), a grant from the National Cancer Institute to P.A.S., and partially by a Cancer Center Support core grant from the National Cancer Institute. C.D.N. was supported by the NIH.
Author information
Authors and Affiliations
Corresponding author
Related links
Related links
DATABASES
Swiss-Prot
FURTHER INFORMATION
National Center for Biotechnology Information
Ambion's siRNA target finder and design tool
Biocomputing at Whitehead Institute
The Hannon lab's siRNA selection site
Glossary
- RIBOZYME TECHNOLOGY
-
This method uses an RNA molecule that binds the target messenger RNA in a sequence-specific manner and catalyses the cleavage of the mRNA. This ribozyme thereby prevents translation of the target mRNA into protein.
- ANTISENSE TECHNOLOGY
-
This method uses either DNA or RNA molecules that are complementary to sequences on the target messenger RNA and inhibits protein production.
- RNASE III
-
A double-stranded (ds)RNA-specific endoribonuclease that cleaves long dsRNA into short fragments that have a characteristic 3′ overhang and a recessed 5′ phosphate on each strand.
- PAZ
-
(PIWI, argonaute and zwille). A putative protein interaction domain named after the founding members that contain this domain.
- PIWI DOMAIN PROTEINS
-
Proteins that have a conserved protein domain of unknown function. In Drosophila, this family has been implicated in translational control and silencing of numerous copies of the alcohol dehydrogenase gene.
- PPD PROTEIN
-
A protein that has a PAZ/PIWI domain.
- INTERFERON
-
A small and highly potent molecule that functions in an autocrine and paracrine manner, and that induces cells to resist viral replication.
- 2′–5′ OLIGOADENYLATE SYNTHASE
-
A component of the interferon-response pathway that, when activated by long double-stranded RNA, catalyses the conversion of ATP to 2′–5′ A oligonucleotides.
- RNASE L
-
An enzyme that is activated by 2′–5′ A oligonucleotides, leading to the cleavage of several RNA species including ribosomal RNA, resulting in an inhibition of messenger RNA translation.
- PKR
-
A protein kinase that, when activated by long double-stranded RNA, phosphorylates and inactivates the translation initiation factor eIF2α, resulting in an inhibition of messenger RNA translation initiation.
- SYNTHETIC OLIGODEOXYRIBONUCLEOTIDE/ RNASEH METHOD
-
A method that is used for mapping endonuclease-sensitive sites and for inhibiting gene expression. Synthetic single-stranded oligodeoxy-ribonucleotide and a complementary sequence to a target messenger RNA are transfected into cells, leading to the formation of an RNA–DNA hybrid. Endogenous RNase H cleaves the RNA molecule of an RNA–DNA hybrid and prevents protein synthesis.
- RNA POLYMERASE II
-
(pol II). The enzyme that transcribes messenger RNA and most of the small nuclear RNAs of eukaryotes, in conjunction with various transcription factors.
- RNA POLYMERASE III
-
(pol III). The enzyme that transcribes stable RNA products that are not translated into proteins, particularly transfer RNAs. However, pol III also transcribes the 5S ribosomal RNA, 7SL RNA and U6 small nuclear RNA.
- CIS-ACTING ELEMENT
-
An arrangement of sequences on a contiguous piece of DNA.
- TANDEM PROMOTERS
-
Promoters that are arranged in the same orientation in close proximity on a contiguous piece of DNA.
- LONG TERMINAL REPEAT
-
(LTR). A sequence that is repeated at both ends of a retroviral DNA that is required for retroviral insertion into its target genomic DNA.
- REVERSE TRANSCRIPTASE
-
An enzyme that is used by retroviruses and retrotransposons to synthesize DNA.
- RAG-DEFICIENT BLASTOCYSTS
-
Blastocysts derived from mice that lack the recombinase-activating gene. Mice that are RAG deficient are unable to produce mature B and T cells and are therefore immunocompromised.
Rights and permissions
About this article
Cite this article
Dykxhoorn, D., Novina, C. & Sharp, P. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 4, 457–467 (2003). https://doi.org/10.1038/nrm1129
Issue Date:
DOI: https://doi.org/10.1038/nrm1129
This article is cited by
-
In vivo inhibition of the Ostreid Herpesvirus-1 (OsHV-1) replication in juveniles of the Pacific oyster Crassostrea gigas by a specific RNAi targeting the viral DNA polymerase gene
Aquaculture International (2023)
-
Using BERT to identify drug-target interactions from whole PubMed
BMC Bioinformatics (2022)
-
Single-molecule FRET uncovers hidden conformations and dynamics of human Argonaute 2
Nature Communications (2022)
-
Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy
3 Biotech (2022)
-
RGS3L allows for an M2 muscarinic receptor-mediated RhoA-dependent inotropy in cardiomyocytes
Basic Research in Cardiology (2022)